MDxHealth SA (MDXH) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MDXH currently has 49.5M outstanding shares. with moderate dilution risk from 14.7M authorized shares representing 29.6% potential dilution. The company has significantly diluted shareholders by 81.39% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Dec 29, 2025 |
F-3 filing: MDXHEALTH SA is offering ordinary shares with an aggregate offering price of up to $50,000,000 through an at-the-market offering via TD Securities (USA) LLC. |
49M | 15M |
| Mar 31, 2025 |
20-F filing | 49.5M shares outstanding |
49M | 0 |
| Jun 28, 2024 |
F-3 filing: This is an F-3 filing regarding the resale of common stock by selling securityholders after the exercise of warrants. |
27M | 0 |
| Apr 30, 2024 |
20-F filing | 27.3M shares outstanding |
27M | 0 |
| Dec 19, 2022 |
F-3 filing: The company is filing an F-3 to register the offering of ordinary shares and American Depositary Shares up to an aggregate amount of $150,000,000. |
160M | 0 |
| Apr 25, 2022 |
20-F filing | 156.0M shares outstanding |
160M | 0 |
| Oct 13, 2021 |
F-1 filing: This F-1 filing registers American Depositary Shares (ADSs) for ordinary shares with no par value. It details fees associated with ADSs, depositary services by The Bank of New York Mellon, use of proceeds for product development and working capital, and risk factors for investors. |
120M | 0 |